Literature DB >> 14419449

Megaloblastic anaemia due to anticonvulsant therapy: report of a case responding to vitamin B12.

P C MACINTOSH, J L HUTCHISON.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPERCHROMIC/etiology; HYDANTOINS/toxicology; PHENOBARBITAL/toxicology; VITAMIN B 12/therapy

Mesh:

Substances:

Year:  1960        PMID: 14419449      PMCID: PMC1937785     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  20 in total

1.  Megaloblastic anaemia during primidone therapy; report of a case responding to vitamin B12.

Authors:  D MONTGOMERY; J CRAIG
Journal:  Scott Med J       Date:  1958-11       Impact factor: 0.729

2.  Megaloblastic anaemia occurring during treatment of epilepsy with phenytoin sodium, primidone and phenobarbitone.

Authors:  R C BENIANS; R A HUNTER
Journal:  J Ment Sci       Date:  1957-07

3.  Megaloblastic anemia following the use of primidone.

Authors:  M J NEWMAN; D W SUMNER
Journal:  Blood       Date:  1957-02       Impact factor: 22.113

4.  The advantages of cobalt 58 tagged vitamin B12 in the study of vitamin B12 absorption.

Authors:  J L HUTCHISON; S R TOWNSEND; D G CAMERON
Journal:  Can Med Assoc J       Date:  1958-05-01       Impact factor: 8.262

5.  Megaloblastic anaemia associated with anticonvulsant drug therapy.

Authors:  J B STOKES; C FORTUNE
Journal:  Australas Ann Med       Date:  1958-05

6.  Observations on megaloblastic anaemias after primidone.

Authors:  H FULD; E H MOORHOUSE
Journal:  Br Med J       Date:  1956-05-05

7.  Megaloblastic anaemia due to phenytoin sodium.

Authors:  E G RHIND; S VARADI
Journal:  Lancet       Date:  1954-10-30       Impact factor: 79.321

8.  Megaloblastic anaemia and anticonvulsant therapy.

Authors:  J N M CHALMERS; K BOHEIMER
Journal:  Lancet       Date:  1954-10-30       Impact factor: 79.321

9.  Megaloblastic anaemia due to phenytoin sodium.

Authors:  C F HAWKINS; M J MEYNELL
Journal:  Lancet       Date:  1954-10-09       Impact factor: 79.321

10.  Megaloblastic anemia during primidone (mysoline) therapy.

Authors:  W N CHRISTENSON; J E ULTMANN; D M ROSEMAN
Journal:  J Am Med Assoc       Date:  1957-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.